Autonomous Infusion Pump Request for Information
ID: FA805225AFMED1006Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE AIR FORCEFA8052 773 ESSSAN ANTONIO, TX, 78236-0119, USA

NAICS

Surgical and Medical Instrument Manufacturing (339112)

Original Source

https://sam.gov/opp/9237cdf10eb64ca8812e85721054dbba/view
Timeline
    Description

    The Department of Defense, specifically the Air Force Medical Command (AFMEDCOM), is issuing a Request for Information (RFI) to identify market capabilities for an autonomous infusion pump designed to enhance patient care in military environments. The RFI seeks information on products that can provide real-time, adaptive fluid resuscitation, thereby alleviating provider workload and minimizing medical errors in resource-limited situations. This initiative is crucial for improving operational efficiency and patient safety within the Air Force Medical Service, as it aims to develop a reliable and innovative medical device that meets stringent safety and performance standards. Interested companies, both large and small, are encouraged to respond by April 30, 2025, and can direct inquiries to Wayne Pernell at usaf.detrick.afmra.mbx.sg5t-market@health.mil.

    Point(s) of Contact
    Wayne Pernell
    usaf.detrick.afmra.mbx.sg5t-market@health.mil
    Files
    Title
    Posted
    AFMEDCOM_A5T_Request for Information_Autonomous Infusion Pump.docx
    The Air Force Medical Command (AFMEDCOM) is issuing a Request for Information (RFI) to assess market capabilities for an autonomous infusion pump designed to enhance patient care in military environments. The RFI aims to identify existing products capable of providing real-time, adaptive fluid resuscitation, alleviating provider workload and minimizing medical errors in situations with limited resources. Companies, both large and small, are encouraged to respond, particularly those within the Surgical and Medical Instrument Manufacturing industry (NAICS 339112). Respondents are asked to describe their capabilities and provide details on how their products align with the key system attributes needed for this device. The RFI includes forms for potential respondents to complete, with a total of 68 Key System Attributes outlined separately. Submission deadlines are established, with the response to be delivered via email and replies expected from companies by April 30, 2025. This RFI aims to improve operational efficiency and patient safety within the Air Force Medical Service by exploring innovative medical devices.
    Copy of 20250328_Autonomous Infusion Pump_RFI_ Response Form_2.xlsx
    The document is a response form outlining the key system attributes (KSA) required for an autonomous infusion pump intended for medical use. It details a series of essential criteria that the vendor must meet, including compliance with ISO and FDA safety standards, automation capabilities that incorporate patient physiology, and user-friendly interfaces. The infusion pump should support multi-channel operations, maintain historical infusion records, and ensure the safety of alarm functionalities. Other vital features include compatibility with various patient populations, device maintainability by biomedical technicians, and robust connectivity options for electronic health records. The pump must also be designed for durability in challenging conditions, with provisions for battery life, weight specifications, and operational noise considerations. The overall objective is to create a reliable, efficient, and safe infusion system that enhances medical care during transport and in various healthcare settings. This document serves as a guide for manufacturers responding to government requests for proposals, emphasizing the need for innovation in medical device technology while aligning with federal, state, and local standards.
    Lifecycle
    Title
    Type
    Autonomous Infusion Pump Request for Information
    Currently viewing
    Sources Sought
    Similar Opportunities
    Analgesic Ketamine for Battlefield Use
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is conducting a Request for Information (RFI) for the development of an analgesic ketamine product intended for battlefield use. This initiative aims to identify industry partners capable of creating a solution for acute severe pain resulting from battlefield injuries, with a focus on products that are suitable for austere, pre-hospital conditions and do not require refrigeration or reconstitution. The desired ketamine formulations may include various delivery methods such as autoinjectors, oral capsules, and topical applications, and must be operable in extreme temperatures with a shelf life of 2-3 years. Interested parties are required to submit a Capabilities Statement by January 12, 2026, detailing their product characteristics, manufacturing capabilities, and FDA approval strategies. For further inquiries, contact Jeanette Collins at jeanette.m.collins4.civ@health.mil or Shannon Lertora at shannon.p.lertora.civ@health.mil.
    Request for Information (RFI) - Equipment Maintenance Database
    Dept Of Defense
    The Department of Defense, through the Army Contracting Command at Aberdeen Proving Ground, is seeking information on commercial solutions for an Equipment Maintenance Database as part of its Soldier Medical Devices Program. This Request for Information (RFI) aims to identify subscription-based services that include a Biomedical Preventive Maintenance Database, along with various other databases essential for managing healthcare operations and ensuring regulatory compliance. The selected solution must support 80 concurrent users, be cloud-based, and compatible with government IT systems, with a contract period of one year and four optional renewals. Interested parties should submit their responses, including detailed white papers and company information, to Patrick Wallace or Trisha Scott via email by the specified deadline.
    BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is conducting market research for the development of a barrier combination product aimed at preventing and treating battlefield wounds and subsequent infections. This initiative, part of the Battlefield Wound Infection Prevention and Treatment (BWI P&T) program, seeks to identify commercial solutions that can effectively address the unique challenges of wound care in austere environments, where medical resources may be limited. The barrier combination product is expected to play a crucial role in a Family of Systems (FoS) approach, providing innovative solutions for both military and commercial applications in wound care. Interested parties are invited to submit their responses by January 20, 2026, at 2:00 PM Eastern, via email to the primary contacts, Jeanette Collins and Julie Burns, whose emails are provided in the opportunity overview. This RFI is for planning purposes only, and no contract will be awarded based on the responses received.
    Stryker/Physio-Control Lifepak 15 Monitor/Defibrillators
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking procurement for the Lifepak 15 Monitor/Defibrillator, specifically the LIFEPAK 15/ACPA Bundle. This equipment is critical for medical and surgical applications, providing essential monitoring and defibrillation capabilities in emergency situations. Interested vendors can reach out to Anthony Giunta at Anthony.Giunta@dla.mil or by phone at 215-737-2126 for further details regarding the procurement process. The opportunity emphasizes the importance of reliable medical instruments in supporting military operations and ensuring the health and safety of personnel.
    JPEO-CBRND RFI - Innovation in Biologics Manufacturing
    Dept Of Defense
    The Department of Defense, through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), is issuing a Request for Information (RFI) focused on innovations in biologics manufacturing. This RFI seeks information on capabilities and technologies related to biologics manufacturing, specifically targeting cell-free production capabilities, advancements in process control, and methods to expedite drug substance release. The initiative aims to enhance medical solutions for crisis response and improve preparedness against future threats. Interested parties are encouraged to share their capabilities via the Joint Enterprise Technology Tool (JETT) platform, with no commitment from the government to issue a subsequent Request for Proposal (RFP).
    Zoll R Series, Advanced Life Support (ALS) Monitor/Defibrillator with Expansion Pack, Pulse Oximetry (SPO2), End-Tidal Carbon Dioxide (EtCO2) (MAINSTREAM), OneStep Pacing, and Non-Invasive Blood Pressure (NIBP
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking to procure the Zoll R Series Advanced Life Support (ALS) Monitor/Defibrillator, which includes an expansion pack, pulse oximetry (SPO2), end-tidal carbon dioxide (EtCO2), OneStep pacing, and non-invasive blood pressure (NIBP) capabilities. This procurement aims to enhance medical response capabilities by providing advanced monitoring and defibrillation equipment essential for emergency medical services. The equipment is critical for ensuring effective patient care in various medical situations, particularly in military and emergency response settings. Interested vendors can reach out to Anthony Giunta at Anthony.Giunta@dla.mil or by phone at 215-737-2126 for further details regarding this opportunity.
    R Series Advanced Life Support Monitor/Defibrillator
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking procurement for the R Series Advanced Life Support Monitor/Defibrillator. This equipment is critical for medical and surgical applications, specifically categorized under the PSC code 6515, which encompasses medical instruments, equipment, and supplies. The monitor/defibrillator plays a vital role in emergency medical situations, providing essential life support capabilities. Interested vendors can reach out to Anthony Giunta at Anthony.Giunta@dla.mil or by phone at 215-737-2126 for further details regarding this opportunity.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense (DoD) is issuing a Request for Quotation (RFQ) for pharmaceutical agents to be included in the Uniform Formulary (UF) as part of a Blanket Purchase Agreement (BPA) and Additional Discount Program (ADP) for Military Treatment Facilities (MTFs) and TRICARE pharmacies. This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on the clinical and cost-effectiveness of drugs, which will be evaluated by the Pharmacy and Therapeutics (P&T) Committee. Key drugs under consideration include newly approved agents for lung cancer, antihypertensive agents, oncological agents, diuretics, antilipidemics, and targeted immunomodulatory biologics, with quotes due by January 5, 2026, for a committee meeting scheduled for February 4-5, 2026. Interested manufacturers should contact Tracy Banks or Julia Trang via email for further details and ensure compliance with submission requirements outlined in the RFQ document HT9402-26-Q-9103.
    NSN2915-01-206-0654NZ_ControllerFuelPum_F100_PN4080022_FD2030-22-01876-02
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency, is conducting market research for the manufacture of the CONTROLLER, FUEL PUMP (NSN: 2915-01-206-0654NZ, P/N: 4080022) with an estimated requirement of 1,500 units. This Sources Sought Synopsis aims to identify potential sources, including small businesses, and to determine the best acquisition strategy for this critical component used in military aircraft operations. Interested parties must be capable of providing all necessary labor, materials, and logistics support, and are required to submit a Source Approval Request (SAR) package by December 17, 2025, to the 430th Supply Chain Management Squadron. For further inquiries, interested vendors can contact the primary contact at 430scms.afmc.rfiresponses@us.af.mil or the secondary contact, Terri Swain Wooten, at terri.swain-wooten@us.af.mil.
    MTEC-26-01-BloodBag Request for Project Proposals Pre-Announcement
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for the manufacturing of single blood donor collection and storage bags within the Continental United States (CONUS). This initiative aims to address the critical shortage of blood storage bags, particularly for use in forward military operations, by establishing domestic manufacturing capabilities to ensure rapid production in times of need. The selected proposals will focus on producing blood bags that meet specific FDA and military standards, with an expected funding availability of up to $4 million for initial awards ranging from $1 to $3 million, and a performance period not exceeding 42 months. Interested parties should contact Dr. Chuck Hutti at chuck.hutti@ati.org for further inquiries and must be members of the Medical Technology Enterprise Consortium (MTEC) to submit proposals, which are anticipated to be released shortly.